Express News | Creative Medical Technology Holdings, Inc. Advances FDA Cleared Adapt Clinical Trial With Positive Independent Review, Validating the Safety and Potential of Celz-201 for Chronic Lower Back Pain Treatment

ReutersNov 13 09:00 ET

Creative Medical Technology Holdings, Inc. Advances FDA Cleared ADAPT Clinical Trial With Positive Independent Review, Validating the Safety and Potential of CELZ-201 for Chronic Lower Back Pain Treatment

GlobeNewswireNov 13 09:00 ET

Creative Medical Technology Holdings Third Quarter 2024 Earnings: US$0.75 Loss per Share (Vs US$1.02 Loss in 3Q 2023)

Yahoo FinanceNov 10 09:19 ET

Creative Medical Technology | 10-Q: Q3 2024 Earnings Report

SECNov 8 16:50 ET · Announcements

Creative Medical Technology Files to Sell 837,104 Shares of Common for Holders

TipRanksNov 8 16:10 ET

Express News | Creative Medical Technology Files Patent For "AI Enhanced Real-Time Biological Optimization And Health Monitoring For Space Travel"

BenzingaNov 7 13:22 ET